Stay updated on RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the Record History, replacing Revision: v3.5.3. This indicates a small update to the page's version metadata.
    Difference
    0.1%
    Check dated 2026-05-14T22:22:22.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.5.3 is now shown, replacing the previous v3.5.2. This indicates a new site release affecting the interface and underlying system, not the study details.
    Difference
    0.1%
    Check dated 2026-04-30T16:50:55.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:09:27.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The two screenshots show the same record history entries with no added or removed versions; the content on the page remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-02T04:55:42.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-03-25T21:36:03.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and deleted Revision: v3.4.3 from the revision history.
    Difference
    0.1%
    Check dated 2026-03-18T18:21:43.000Z thumbnail image

Stay in the know with updates to RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.